← Eichor
Condition: Antineoplastics Toxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antineoplastics Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune Checkpoint Inhibitors Nephrotoxicity
Phase N/A · 2 location(s) · R. Laura Vicente Vicente · NCT04902846Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Phase N/A · 2 location(s) · Universitair Ziekenhuis Brussel · NCT06387901Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Horm
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06621459GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07511413The STOP-MED CTRCD Trial
Phase 4 · 14 location(s) · Dinesh Thavendiranathan · NCT06183437Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients
NA · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07514754
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.